MSI Methylation is a pharmaceutical company that develops molecule therapies for the treatment of Major Depressive Disorder.
Business Model:
Revenue: $10.4M
Employees: 51-200
Address: 4075 B McConnell Drive
City: Burnaby
State: british columbia
Zip: V5A 3A7
Country: CA
MSI Methylation is a pharmaceutical company that develops molecule therapies for the treatment of Major Depressive Disorder.
Contact Phone:
+16044355155
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2016 | Venture Round | 1 | $30M |
Quark Venture Quark Venture |
9/2011 | Series A | 3 | $18.4M |
GrowthWorks Capital Inventages Venture Capital Investment Inc. Working Opportunity Fund GrowthWorks Capital Inventages Venture Capital Investment Inc. Working Opportunity Fund |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|